Mayne Pharma Group Limited (ASX:MYX)
Australia · Delayed Price · Currency is AUD 2.570
-0.020 (-0.77%)
Apr 24, 2026, 4:11 PM AEST
Mayne Pharma Group Market Cap
Mayne Pharma Group has a market cap or net worth of 208.8 million as of April 24, 2026. Its market cap has decreased by -64.36% in one year.
Market Cap
208.80M
Enterprise Value
183.82M
Revenue
407.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.57
Market Cap Chart
Since June 29, 2007, Mayne Pharma Group's market cap has increased from 45.66M to 208.80M, an increase of 357.30%. That is a compound annual growth rate of 8.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 208.80M | -17.36% |
| Dec 31, 2025 | 252.67M | -37.42% |
| Dec 31, 2024 | 403.79M | -19.19% |
| Dec 29, 2023 | 499.66M | 43.60% |
| Dec 30, 2022 | 347.96M | -33.16% |
| Dec 31, 2021 | 520.63M | -10.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 61.85B |
| Sigma Healthcare | 32.32B |
| Pro Medicus | 14.80B |
| Sonic Healthcare | 9.98B |
| Paragon Care | 264.85M |
| Tetratherix | 237.08M |
| Dimerix | 231.15M |
| Orthocell | 230.61M |